Lagos State Univ, Dept Pharmacol Therapeut & Toxicol, Coll Med, Ikeja 100271, Lagos, Nigeria.;Lagos State Univ, Dept Med, Teaching Hosp, Ikeja 100271, Nigeria..
Sefako Makgatho Hlth Sci Univ, Sch Pharm, Dept Publ Hlth Pharm & Management, ZA-0208 Ga Rankuwa, South Africa..
Gonoshasthaya Somaj Vittik Med Coll, Dept Pediat, Dhaka 1344, Bangladesh..
Hurbert Kairuki Mem Univ, Dept Clin Pharmacol & Therapeut, POB 65300,70 Chwaku Rd Mikocheni, Dar Es Salaam, Tanzania..
Sefako Makgatho Hlth Sci Univ, Sch Pharm, Dept Publ Hlth Pharm & Management, ZA-0208 Ga Rankuwa, South Africa..
Boston Univ, Dept Biomed Engn, Coll Engn, Boston, MA USA.;Boston Univ, Inst Hlth Syst Innovat & Policy, Boston, MA USA..
City St Georges Univ London, Inst Infect & Immun, Ctr Neonatal & Paediat Infect, London SW17 0RE, England.;Univ Oxford, Hlth Econ Res Ctr, Nuffield Dept Populat Hlth, Oxford OX1 2JD, England..
Kamuzu Univ Hlth Sci KUHeS, Formerly Coll Med, Pharm Dept, POB 278, Blantyre, Malawi..
Univ Zimbabwe, Fac Med & Hlth Sci, POB MP167, Harare, Zimbabwe..
City St Georges Univ London, Inst Infect & Immun, Ctr Neonatal & Paediat Infect, London SW17 0RE, England..
City St Georges Univ London, Inst Infect & Immun, Ctr Neonatal & Paediat Infect, London SW17 0RE, England..
City St Georges Univ London, Inst Infect & Immun, Ctr Neonatal & Paediat Infect, London SW17 0RE, England..
HERD Int, Lalitpur, Nepal.;Publ Hlth Res Soc, Kathmandu, Nepal..
Sefako Makgatho Hlth Sci Univ, Sch Pharm, Dept Publ Hlth Pharm & Management, ZA-0208 Ga Rankuwa, South Africa.;Hawler Med Univ, Coll Pharm, Dept Clin Pharm, Erbil, Iraq.;Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci SIPBS, Glasgow City G4 0RE, Scotland.;Al Kitab Univ, Coll Pharm, Kirkuk 36015, Iraq..
Univ Strathclyde, Strathclyde Business Sch, Management Sci Dept, 199 Cathedral St, Glasgow City G4 0QU, Scotland..
Dubai Municipal, Hlth & Safety Dept, Dubai, U Arab Emirates.;Ajman Univ, Ctr Med & Bioallied Hlth Sci Res, Ajman, U Arab Emirates.;Ajman Univ, Coll Pharm & Hlth Sci, Dept Clin Sci, Ajman, U Arab Emirates..
Natl Def Univ Malaysia, Univ Pertahanan Nas Malaysia, Fac Med & Def Hlth, Unit Pharmacol, Kuala Lumpur 57000, Malaysia.;Karnavati Univ, Karnavati Sci Res Ctr, Karnavati Sch Dent, Gandhinagar 382422, Gujarat, India..
Sefako Makgatho Hlth Sci Univ, Sch Pharm, Dept Publ Hlth Pharm & Management, ZA-0208 Ga Rankuwa, South Africa.;Univ Manchester, Sch Hlth Sci, Manchester, England..
Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Infect Dis & HIV Med, Cape Town, South Africa..
City St Georges Univ London, Inst Infect & Immun, Ctr Neonatal & Paediat Infect, London SW17 0RE, England.;Sefako Makgatho Hlth Sci Univ, Sch Pharm, Dept Publ Hlth Pharm & Management, ZA-0208 Ga Rankuwa, South Africa.;Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci SIPBS, Glasgow City G4 0RE, Scotland.;Ajman Univ, Ctr Med & Bioallied Hlth Sci Res, Ajman, U Arab Emirates..
City St Georges Univ London, Inst Infect & Immun, Ctr Neonatal & Paediat Infect, London SW17 0RE, England..
Background
There are concerns globally with rising rates of antimicrobial resistance (AMR), particularly in low- and middle-income countries (LMICs). AMR is driven by high rates of inappropriate prescribing and dispensing of antibiotics, particularly Watch antibiotics. To develop future interventions, it is important to document current knowledge, attitudes and practices (KAP) among key stakeholder groups in LMICs.
Methods
We undertook a narrative review of published papers among four WHO Regions including African and Asian countries. Relevant papers were sourced from 2018 to 2024 and synthesized by key stakeholder group, country, WHO Region, income level and year. The findings were summarized to identify pertinent future activities for all key stakeholder groups.
Results
We sourced 459 papers, with a large number coming from Africa (42.7%). An appreciable number dealt with patients’ KAP (33.1%), reflecting their influence on the prescribing and dispensing of antibiotics. There was marked consistency of findings among key stakeholder groups across the four WHO Regions, all showing concerns with high rates of prescribing of antibiotics for viral infections despite professed knowledge of antibiotics and AMR. There were similar issues among dispensers. Patients’ beliefs regarding the effectiveness of antibiotics for self-limiting infectious diseases were a major challenge, although educational programmes did improve knowledge. The development of the AWaRe (Access, Watch and Reserve) system, including practical prescribing guidance, provides a future opportunity for the standardization of educational inputs.
Conclusions
Similar KAP regarding the prescribing and dispensing of antibiotics across LMICs and stakeholder groups presents clear opportunities for standardization of educational input and practical training programmes based on the AWaRe system.
Oxford University Press, 2025. Vol. 7, no 2, article id dlaf033